Endoscopic prediction of depth of tumor invasion in early gastric cancer in the upper third of the stomach. A phase 2 study of durvalumab plus DOS (docetaxel, oxaliplatin, S-1) neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback